Over 72 weeks patients without diabetes lost 15%, 19%, and 21% of body weight on the 5, 10, and 15 mg weekly SQ injections, respectively
The development of innovative herbal drug delivery systems holds promise in enhancing patient compliance, stability, dosing flexibility, bioavailability, and reducing toxicity in herbal drug research [83]
GLP-1 therapy creates a metabolic window where your body can relearn balance
Tirzepatide (Mounjaro, Zepbound) is a related but distinct medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor co-agonist
A patient with treatment resistant schizophrenia gains 40 pounds on clozapinethe only antipsychotic that worked well for his symptoms
The drug is currently marketed as Victoza for Type 2 diabetes and as Saxenda for long-term weight management in people with obesity